Traditional Chinese medicines are beneficial in the treatment of COVID-19, particularly mild to moderate cases, according to a new report released by the World Health Organization.

世界卫生组织日前发布的一份新报告指出，中医药能有效治疗新冠肺炎，对轻型和普通型病例尤其有效。

It also encourages member states to consider the potential use of TCM for the management of COVID-19 in the context of their healthcare systems and regulatory frameworks.

世卫组织鼓励会员国在其卫生保健系统和监管框架内考虑使用中医药治疗新冠肺炎的可能性。

The report came in late March after a WHO Expert Meeting on Evaluation of TCMs in the Treatment of COVID-19 was held virtually from Feb 28 to March 2.

世卫组织中医药救治新冠肺炎专家评估会于2月28日至3月2日以视频会议形式召开。

The meeting gathered 21 international experts from the six WHO regions to consider three reports, including on clinical service, research and evidence-based evaluation provided by national expert groups in China.

来自世卫组织6个地区办事处的21名国际专家围绕临床实践、科学研究和循证评价等方面展开研讨，对中方专家分享的关于中医药救治新冠肺炎相关报告进行了交流和评估，并于3月底形成专家评估会报告。

【世卫报告充分肯定中医药抗疫贡献查看网站：[db:时间]】